Abbonarsi

Nanosuspensions: Enhancing drug bioavailability through nanonization - 18/07/24

Nanosuspensions : améliorer la biodisponibilité des médicaments par la nanonisation

Doi : 10.1016/j.pharma.2024.06.003 
Rohit Chavhan
 Yash institute of pharmacy, Dharmapur, India 

In corso di stampa. Prove corrette dall'autore. Disponibile online dal Thursday 18 July 2024

Highlights

Nanosuspensions revolutionize drug delivery: nanosuspensions represent a cutting-edge dosage form with the potential to transform drug delivery by enhancing the bioavailability of poorly soluble medications.
Critical role of particle size reduction: nanonization techniques play a pivotal role in reducing particle size, thereby overcoming challenges associated with low solubility in both aqueous and organic environments.
Versatility in administration routes: nanosuspensions offer versatility in administration routes, spanning parenteral, peroral, ocular, and pulmonary pathways, making them suitable for various dosage forms.
Diverse preparation techniques: various preparation techniques such as high-pressure homogenization, media milling, and precipitation contribute to the expanding repertoire of nanosuspension formulation methods, each offering unique advantages and limitations.
Focus on targeted drug delivery: ongoing research aims to further nanosuspensions’ application in site-specific drug delivery, indicating their potential for tailored therapeutic strategies.
Importance of formulation and stabilization: careful formulation and stabilization using polymers and surfactants are essential to ensure the efficacy and safety of nanosuspensions.
Comprehensive overview: the article provides a comprehensive overview of nanosuspensions, covering their benefits, drawbacks, characterization, patents, marketed products, and intended uses, serving as a valuable resource for future research endeavors in pharmaceutical sciences.

Il testo completo di questo articolo è disponibile in PDF.

Summary

Introduction

Nanosuspensions have emerged as a promising avenue in pharmaceutical innovation, particularly for enhancing the bioavailability of poorly soluble medications. This article explores the transformative potential of nanosuspensions, emphasizing the critical role of particle size reduction through nanonization techniques. With conventional approaches often falling short in addressing the bioavailability challenges of hydrophobic drugs, nanosuspensions offer multifaceted applications and distinctive advantages in drug delivery.

Methods

The study delves into various nanosuspension preparation techniques, including high-pressure homogenization, media milling, emulsification-solvent evaporation, precipitation, and supercritical fluid processes. Each method brings unique advantages and limitations, contributing to the expanding repertoire of nanosuspension formulation methods. The article emphasizes the necessity for meticulous planning, evaluation, and ongoing research across different drugs to optimize their use effectively.

Results

Nanosuspensions exhibit versatility in administration routes, spanning parenteral, peroral, ocular, and pulmonary pathways, making them applicable across diverse dosage forms. Current efforts are directed towards furthering their application in site-specific medication administration, indicating their potential in tailored therapeutic strategies. Nanosuspensions offer a promising solution for enhancing drug solubility and bioavailability, addressing the persistent challenge of poor solubility in pharmaceutical compounds.

Discussion

The significance of careful formulation and stabilization using polymers and surfactants is underscored, ensuring the efficacy and safety of nanosuspensions. By discussing the benefits, drawbacks, and nuances of each preparation technique, the article aims to simplify future research endeavors in the field of nanosuspensions. Additionally, a comprehensive overview of nanosuspensions, including their preparation methods, benefits, characterization, patents, marketed products, and intended uses, sheds light on this evolving domain in pharmaceutical sciences.

Conclusion

Nanosuspensions represent a promising approach for overcoming bioavailability challenges associated with poorly soluble medications. The article highlights their transformative potential in pharmaceutical innovation, emphasizing the importance of continued research and optimization to harness their benefits effectively. Nanosuspensions offer a viable solution for enhancing drug solubility and bioavailability, with implications for improving therapeutic outcomes in various medical conditions.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Nanosuspension, Nanonization, Bioavailability enhancement, Formulation techniques, Drug solubility, Versatile drug delivery


Mappa


© 2024  Académie Nationale de Pharmacie. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.